neuroinflammation induced by systemic injection of lipopolysaccharide (LPS) and ischemic stroke following middle cerebral artery ligation (Zamanian et al., 2012) . LPS-induced A1 astrocytes upregulate the classical complement pathway genes, thus resulting in injury of synapses during neuroinflammation. Ischemia-induced A2 astrocytes upregulate neurotrophic factors that promote CNS recovery and repair (Sofroniew and Vinters, 2010; Zador et al., 2009) . A1 astrocytes induced by activated microglia have neurotoxic functions (Liddelow and Barres, 2017; . A better understanding of the phenotype switch in reactive astrocytes may contribute to the development of novel therapies to decrease neurological impairment in neurodegenerative diseases. Impaired insulin signaling occurs in both diabetes and Alzheimer's disease (AD), where it may promote inflammation (Bomfim et al., 2012) . Astrocytes are insulin responsive and uptake glucose, which is essential for neuron energy metabolism. Insulin inhibits the expression of nitric oxide synthase and oxidative damage induced by LPS and H 2 O 2 in astrocytes (Ramalingam and Kim, 2014) . Insulin signaling deficits lead to hyperphosphorylation of Tau and the formation of neurofibrillary tangles found in neurodegenerative disorders such as AD and Parkinson's disease (Calvo-Ochoa et al., 2014) . Tau kinases, such as glycogen synthase kinase 3 beta (GSK3β), promote insulin-modulated Tau phosphorylation via the phosphatidylinositol kinase (PI3K)/protein kinase B (AKT) pathway (Flores et al., 2008; Schubert et al., 2004) . Insulin resistance leads to Tau hyperphosphorylation by inhibition of AMPK-induced Tau de-phosphorylation and aberrant activation of GSK3β (Kim et al., 2015; Schubert et al., 2004) .
This study investigated KCa3.1 regulation of astrogliosis-mediated neuroinflammation, Tau accumulation, and insulin signaling deficiency in astrocyte primary cultures and neuronal loss and memory deficits in an LPS-induced mouse model of neuroinflammation.
Material and methods

Compounds and formulations
Senicapoc (ICA-17043, TargetMol, Boston, MA) was dissolved at 100 mM in Dimethyl sulfoxide (Sigma-Aldrich, St. Louis, MO) and diluted in media for in vitro studies. For oral administration to C57BL/6 mice, senicapoc was dissolved in a cremophore EL®/water (10: 90) mixture (Calbiochem®, Merck, Darmstadt, Germany) as a concentration at 100 mg/kg. The endotoxin LPS from Escherichia coli O55:B55 (Sigma-Aldrich, St. Louis, MO; final concentration of 5 mg/kg in vivo) dissolved in normal saline. The LPS (final concentration of 0.1 mg/ml in vitro) was dissolved in Dulbecco's Modified Eagles Medium (DMEM, Invitrogen) and stored at −20°C until use. SB20358, SP600125, LY294002, U0126 and 2-APB were from Tocris Bioscience (Bristol, UK).
Animals
Animal care and procedures were approved by the Animal Experimentation Ethics Committee of Shanghai Jiao Tong University School of Medicine, Shanghai, China (ethics protocol A-2015-010). KCa3.1 −/− knockout mice (KO) were purchased from the Jackson Laboratory (stock no: 018826 B6; 129S1-Kcnn4 tm1Jemn /J) . KO male mice and their Wild-type (WT) littermates weighing 25-30 g were assigned to four groups of 15 mice each and received intraperitoneal injection of either LPS at 5 mg/kg (Zamanian et al., 2012) or an equal volume of the saline vehicle. The mice were evaluated with a water maze test 7 days after treatment and then euthanized for collection of brain tissue for western blotting assays and histological evaluation.
Morris water maze test
The spatial memory of WT and KO mice was evaluated with a modified Morris water maze test as described by Morris et al. (Morris, 1984) . The test was conducted in a circular pool 120 cm in diameter and 50 cm deep, which was equipped with image pickup and video analysis systems (Shanghai Jialiang Software Technology Co, Ltd.). A 4.5 cm diameter escape platform was placed 1 cm below the water surface. To successfully complete the test, the mice were required to find the hidden platform within 60 s. Mice that did not find the platform within 60 s were placed on the platform for 10 s at the end of the testing. The water maze test included 5 days of training with a visible platform on day 1 and a hidden platform on the other 4 days, followed by a practice trial on day 6 without a platform. Each mouse performed two separate trials with the platform, which was removed on the last day. The escape latency and escape distance (the time and distance required to find the hidden platform), swimming distance and swimming time (the distance and time that the mouse remained in the target quadrant), and the time needed to cross the platform were used to evaluate learning and memory.
Immunostaining and image analysis
Brain tissue was collected, prepared, immunostained and evaluated through confocal microscopy as previously described (Yi et al., 2016a; Yi et al., 2016b) . Mice were anesthetized with chloral hydrate and perfused with 4% paraformaldehyde. After embedding in paraffin, sectioning at 12 μm, and mounting, the tissue was dewaxed, rehydrated and blocked by incubation with 10% goat serum in 0.01 M phosphatebuffered saline for 1 h at room temperature. The brain sections were then incubated with rabbit anti-glial fibrillary acidic protein (GFAP, 1:1000; Dako, Glostrup, Denmark), rabbit anti-NeuN (1:100; Merck Millipore, Burlington, MA, USA), or rabbit anti-Iba1 (1:500; Wako Pure Chemical Industries, Ltd., Osaka, Japan), or mouse anti-KCa3.1 (1:100; Alomone Labs, Ltd., Jerusalem, Israel) primary antibodies overnight at 4°C. The tissue sections were incubated with Alexa Fluor 568-conjugated secondary antibodies (1:500; Invitrogen Corporation, Carlsbad, CA, USA). Images were obtained with a TCS SP8 confocal laser scanning microscope (Leica Microsystems, Wetzlar, Germany), and the GFAP, Iba-1 or NeuN positive cell number was counted in a blinded manner, and the area was measured by Leica LAS AF Lite software (Leica, Germany). The same reference point in each brain tissue section was used for three to five 0.01 mm 2 diameter microscopic fields that were randomly selected from the same reference point in each brain tissue section for image analysis. The blinded analysis included six sections from each brain specimen separated by 120 μm intervals. For KCa3.1 immunohistochemistry, the sections were incubated with mouse anti-KCa3.1 (1:100) at 4°C overnight. The following day, sections were treated with biotinylated anti-mouse IgG and then processed with avidin-biotin peroxidase complex. The peroxidase reaction was visualized by 0.05% DAB with 0.03% H 2 O 2 .
Primary astrocyte cultures
Primary mixed glial cell cultures were prepared from brain tissue collected from newborn C57BL/6 J mice (P0-P2), as previously described (Wei et al., 2016) . Cerebral cortex tissue was dissociated into a single-cell suspension through treatment with 0.25% trypsin (Invitrogen) for 15 min at 37°C and mechanical disruption. Cells were grown in DMEM plus 10% fetal bovine serum. The confluent mixed glial cell cultures that formed in 10-14 days were shaken at 200 rpm overnight at 37°C to suspend loosely attached microglia and oligodendrocyte precursor cells. Astrocytes were then harvested by trypsinization of the remaining cells and were transferred to six-well plates. Astrocyte-conditioned medium (ACM) for neuron culture was prepared as previously described (Wei et al., 2016) . Briefly, the astrocyte culture medium was changed from DMEM plus 10% fetal bovine serum to serum-free neurobasal medium (NB, Gibco) with B27 supplement (Invitrogen). Astrocytes in NB/B27 medium were treated with 10 μg/ml LPS for 48 h, and the resulting ACM was collected, centrifuged (1200 rpm, 5 min), and filtered (0.22 μm low-protein binding filter; Millipore, Billerica, MA) to remove the cell debris and LPS. Primary neuron cultures were prepared from newborn (P0-P2) C57BL/6 mice, as described by Wei et al. (Wei et al., 2016) , and cultured in NB/B27 medium for 10-14 days. A Cell Counting Kit-8 (CCK-8, Dojindo Laboratories, Kumamoto, Japan) was used to assay cell viability (Yu et al., 2013) .
Neurite outgrowth assay
Primary neuron cultures were incubated with a primary antibody against microtubule associated protein 2 (MAP2, 1:1000, Abcam) and Alexa Fluor 568-conjugated secondary antibody. MAP2-positive cells were scanned with a Cellomics Kinetic Scan reader (Thermo Fisher Scientific, Waltham, MA, USA). Extended Neurite Outgrowth software (Thermo Fisher Scientific) was used for image analysis.
TNF-α and IL-1β assay
TNF-α and IL-1β protein levels were determined with enzymelinked immunosorbent assay (ELISA) kits (Rapidbio Labs, Langka Trade Co. Ltd., Shanghai, China) according to the manufacturer's instructions.
Western blotting
Mice were anesthetized with chloral hydrate and perfused with saline. Mice brain tissues or primary cells were lysed on ice with radioimmunoprecipitation assay buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate, sodium orthovanadate, sodium fluoride, ethylenediaminetetraacetic acid, leupeptin) containing 1% phenylmethanesulfonyl fluoride. Equal concentrations of proteins were separated by 10% (w/v) sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to a polyvinylidene difluoride membrane, which was blocked for 1 h at room temperature in 5% milk in Tris-buffered saline with 0.05% Tween 20. The membrane was incubated with following primary antibodies overnight at 4°C: KCa3.1 (1:400, ab83740, Abcam), β-actin (1:3000, A1978, Sigma), Phospho-Akt Kit (1:1000, #9916), Phospho-Tau (1:1000, #9632), NF-κB p65 (1:1000, #8242), PSD95 (1:1000, #3407), Phospho-NF-κB p65 (1:1000, #3033, Cell Signaling Technology, Danvers, MA, USA), Orai1 (1:500, H-46), p-IκB-α (1:500, B-9), IκB-α (1:500, H-4), Insulin Rβ (1:1000, sc-377071, Santa Cruz Biotech.), Tau (1:1000, MAB5430, MILLPORE) and the corresponding conjugated anti-rabbit and anti-mouse IgG-horseradish peroxidase (1:2000, Santa Cruz Biotechn, Santa Cruz, CA, USA) secondary antibodies were performed for 1 h at room temperature, and developed using BeyoECL solution (P0018A; Beyotime Institute of Biotechnology). Image Studio Lite Ver 5.2 software (LI-COR Biosciences, Lincoln, NE, USA) was used to analyze the proteins.
Affinity purification of translating RNA, amplification, and sequencing library construction
Total RNA was extracted with TRIzol reagent (Invitrogen Life Technologies), and the concentration, quality, and integrity were determined with a NanoDrop spectrophotometer (Thermo Scientific). Three micrograms of RNA were used as input material for the RNA sample preparations. Sequencing libraries were generated using the TruSeq RNA Sample Preparation Kit (Illumina, San Diego, CA, USA). Briefly, mRNA was purified from total RNA with poly-T oligonucleotide-attached magnetic beads. Fragmentation was carried out at an elevated temperature in a proprietary Illumina fragmentation buffer containing divalent cations. The first strand cDNA was synthesized with random oligonucleotides and SuperScript II. Second strand cDNA synthesis was performed with DNA Polymerase I and RNase H. The remaining overhangs were converted to blunt ends with exonuclease/ polymerase, and the enzymes were then removed. After adenylation of the 3′ ends of the DNA fragments, Illumina PE adapter oligonucleotides were ligated to prepare for hybridization. To select cDNA fragments of the preferred 200 bp in length, the library fragments were purified using the AMPure XP system (Beckman Coulter, Beverly, CA, USA). DNA fragments with ligated adaptor molecules at both ends were selectively enriched with Illumina PCR Primer Cocktail in a 15 cycle PCR. The products were purified in an AMPure XP system and quantified with an Agilent high sensitivity DNA assay on a Bioanalyzer 2100 system (Agilent). The RNA library was then sequenced on the Illumina Hiseq platform by Shanghai Personal Biotechnology Cp. Ltd.
RNA-Seq analysis
Samples are sequenced on the platform to get image files, which are transformed by the software of the sequencing platform, and the original data in FASTQ format (Raw Data) is generated. Sequencing data contains a number of adapters, low-quality reads, so we use Cutadapt (v1.15) software to filter the sequencing data to get high quality sequence (Clean Data) for further analysis. In data mapping analysis, the reference genome and gene annotation files were downloaded from genome website. Reference genome index was built by Bowtie2 (2.2.6) and the filtered reads were mapping to the reference genome using TopHat2 (2.0.14), the default mismatch was no > 2. The alignment region distribution of mapped reads was calculated. For mRNA analysis, we used HTSEq. (0.9.1) statistics to compare the Read Count values on each gene as the original expression of the gene, and then used FPKM to standardize the expression. Then we used DESEq. (1.30.0) to analyze the genes of difference expression with screened conditions as follows: expression difference multiple |log2 fold change| > 1, significant p-value < .05. At the same time, we used R language Pheatmap (1.0.8) software package to perform bi-directional clustering analysis of all different genes of samples. We get heat map according to the expression level of the same gene in different samples and the expression patterns of different genes in the same sample with Euclidean method to calculate the distance and Complete Linkage method to cluster. Next, we mapped all the genes to Terms in the Gene Ontology database and calculated the numbers of differentially enriched genes in each Term. Based on the whole genome, Terms with significant enrichment of differentially enriched genes were calculated by hypergeometric distribution. The purpose of GO enrichment analysis is to obtain GO functional terms with significant enrichment of differentially expressed genes, thus revealing the possible functions of differentially expressed gene in the samples, as well as we counted the number of differentially expressed genes at different levels of KEGG Pathway, and then determined the metabolic pathways and signaling pathways that differentially expressed genes mainly participate in. RNA-seq data has been deposited at: https://dataview.ncbi.nlm.nih.gov/object/PRJNA532295?reviewer= t1qjkmruvftmqoge2eaicj6dut.
Calcium imaging
Purified astrocyte cell suspensions were transferred to 96-well plates containing DMEM plus 10% fetal bovine serum and cultured to confluence before incubation for 25 min with 1.6 μM Fluo-4 AM (Beyotime Institute of Biotechnology), a fluorescent calcium indicator. The cultures were washed three times with 0.01 M PBS before the culture medium was replaced with DMEM plus 2 μM ethylene glycol-bis (β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid to chelate calcium. Then 1 μM thapsigargin (Tg) was added to induce release of [Ca 2+ ] i . When the [Ca 2+ ] i was stable, 2 mM CaCl 2 solution was added to the DMEM to induce Ca 2+ influx. The fluorescence intensity was recorded and analyzed with a FlexStation 3 Multi-Mode Microplate Reader (Molecular Devices, Sunnyvale, CA, USA).
T. Wei, et al. Neurobiology of Disease 132 (2019) 104588 2.12. Statistical analysis All data are presented as the mean ± standard error of the mean. Statistical analyses were performed using Prism software (GraphPad Software, Inc., La Jolla, CA, USA). Data were tested for Gaussian distribution with the Kolmogorov-Smirnov normality test and then analyzed by one-way analysis of variance (ANOVA) and the Dunnett's post hoc test. Statistical significance was set at p < .05.
Results
Loss of KCa3.1 expression decreases LPS-induced memory deficiency and neuronal loss
Systemic LPS injection can cause neuroinflammation and memory dysfunction in rats (Song et al., 2016) . To test the involvement of KCa3.1 channels in the development of AD-like pathology and symptoms, we administered 8-to 10-week old WT (KCa3.1 +/+ ) and KO (KCa3.1 −/− ) mice a single intraperitoneal injection of LPS at 5 mg/kg and tested them in the Morris water maze. The results indicated that knockdown of KCa3.1 expression attenuated the LPS-induced cognitive dysfunction. The WT, KO, WT + LPS, and KO + LPS mice learned to find the hidden platform during a 5-day training period and then were tested for six consecutive days. During the 5-day training period, a spatial learning deficit was observed in WT + LPS mice, as reflected by their requiring more time than the KO + LPS mice to find the hidden platform (Fig. 1A) . The KO + LPS mice were resistant to the LPS-induced cognitive dysfunction. After removal of the escape platform, WT + LPS mice performed fewer platform crossings ( Fig. 1B) , swam shorter distances (Fig. 1C) , and spent less time swimming ( Fig. 1D ) than the KO + LPS mice. Loss of neurons and decrease of synaptic proteins have been found to correlate with AD severity (Pozueta et al., 2013) . The immunostaining results indicated that loss of KCa3.1 expression in KO mice prevented neuron loss following LPS injection. NeuN expression was lower in the cortex and CA1 hippocampus in WT + LPS mice than in WT controls ( Fig. 1E ). NeuN staining was significantly higher in the cortex in KO + LPS mice than in WT + LPS mice. The specificity of the KCa3.1 antibody was shown in the Supplement Fig. 1 .
Co-immunostaining of KCa3.1 with specific for GFAP + astrocytes, Iba-1 + microglia, and NeuN + neurons was performed on brain sections of control and LPS-stimulated mice ( Fig. 1F-H) . In control mice, a low level of expression of KCa3.1 was detected in GFAP + astrocytes, Iba-1 + microglia, and NeuN + neurons ( Fig. 1F-H) . However, at LPS-stimulated mice, we detected a clear colocalization between KCa3.1 and GFAP + reactive astrocytes ( Fig. 1F ). We labeled sections from the LPS groups for KCa3.1 and the Iba1 + microglial. There was little colocalization between KCa3.1 and microglia at LPS groups (Fig. 1G ). KCa3.1 expression was found in NeuN + neurons in the brains of LPS-stimulated mice (Fig. 1H ).
Loss of KCa3.1 expression decreases LPS-induced glial activation
The results suggested that loss of KCa3.1 in KO mice prevented the activation of microglia activation and reactive astrogliosis that accompany LPS-induced neuroinflammation. Microglial activation by KCa3.1 in LPS-induced mice was investigated by immunostaining of Iba1, which is upregulated in reactive microglia. The immunoreactivity of Iba1 was higher in the cortex and the CA1 and DG hippocampus in the WT + LPS mice than in the WT controls, but was lower in the cortex and hippocampus in KO + LPS mice than in WT + LPS mice ( Fig. 2A) . The effect of the absence of KCa3.1 on reactive astrocytes in LPS-induced mice was investigated by immunostaining for GFAP. As shown in Fig. 2B , the GFAP immunoreactivity in the hippocampus was higher in WT + LPS mice than in WT controls, but was lower in KO + LPS mice than WT + LPS mice (Fig. 2B) . These results suggested that gene deletion of KCa3.1 prevented the microglia activation and reactive astrogliosis in LPS-induced neuroinflammation.
Insulin signaling deficiency may contribute to Tau phosphorylation by modulating Tau kinases, including GSK3β, via the PI3K/AKT signaling pathway (Calvo-Ochoa et al., 2014; Schubert et al., 2004) . Western blot assays revealed significantly higher p-Tau expression and significantly lower insulin receptor expression in WT + LPS mice than WT control mice (Fig. 2C ). The lack of KCa3.1 in KO mice attenuated the changes in insulin receptor and p-Tau expression in response to LPS. The changes in insulin receptor and p-Tau expression were accompanied by significant decreases in LPS-stimulated phosphorylation of Akt and GSK3β (Fig. 2C) , and increases in the phosphorylation of p65 and IκB (Fig. 2C ), but these effects were attenuated in KCa3.1-deficient KO mice. Double immunostaining showed that KCa3.1 deficiency attenuated LPS-induced accumulation of insulin and p-Tau in the brain tissue in KO + LPS mice compared with WT + LPS mice ( Fig. 2D) . A clear colocalization between insulin and NeuN + neuron was detected at LPS-stimulated mice ( Fig. 2E ).
Senicapoc inhibits LPS-induced glial activation and neuron loss in vivo
Whether pharmacological blockade of KCa3.1 with senicapoc would attenuate of glial activation and neuron loss in mice treated with LPS was investigated by immunostaining of the astrocytes marker GFAP, microglia marker Iba-1 and neuron marker NeuN. Positive immunostaining of GFAP was significantly increased in the cortex (Fig. 3A, B ) in mice treated with LPS compared with control mice, but not in the hippocampus (Fig. 3G , H). Treatment with senicapoc (100 mg/kg, p.o., once daily, 1 h prior to LPS exposure) attenuated GFAP positive immunostaining in the cortex of mice in the LPS + senicapoc group compared with mice in the LPS group (Fig. 3A, B ). Positive immunostaining of Iba-1 was also significantly increased in both the cortex (Fig. 3C , D) and hippocampus ( Fig. 3I , J) in mice treated with LPS compared with control mice. Treatment with senicapoc attenuated Iba-1 positive immunostaining in the cortex and hippocampus of mice in the LPS + senicapoc group compared with mice in the LPS group.
Immunofluorescence analysis showed that NeuN was decreased in the cortex and hippocampus of LPS mice compared with control mice. Treatment with senicapoc (100 mg/kg, p.o., once daily) led to significantly increased NeuN-positive immunostaining in the cortex (Fig. 3E , F) and hippocampus ( Fig. 3K , L) of the LPS + senicapoc group compared with the LPS group.
3.4. KCa3.1 and Orai1 are involved LPS-induced store-operated calcium entry (SOCE) in astrocytes SOCE channels in the ER are complexes of calcium sensor stromal interaction molecule 1 (STIM1) and pore forming protein calcium release-activated calcium channel protein 1 (Orai1). These channels regulate activation of nonexcitable cells, such as astrocytes and microglia, by triggering Ca 2+ influx Michaelis et al., 2015; Moreno et al., 2012) . The activation of KCa3.1 in mast cells depends on Ca 2+ influx via the Orai1 channel in the plasma membrane (Duffy et al., 2015) . We investigated whether Orai1-mediated SOCE might be involved in KCa3.1 activation and the subsequent release of proinflammatory cytokines in LPS-induced astrogliosis. To investigate SOCE transport, we depleted astrocyte ER Ca 2+ stores with 2 μm Tg, a sarcoplasmic/ER Ca 2+ ATPase pump blocker. As shown in Fig. 4A , in the absence of extracellular Ca 2+ , the Tg-evoked increases in [Ca 2+ ] i (first peak) after 3 h of treatment with 10 μg/ml LPS were no different from those in untreated control astrocytes (Fig. 4A ). The addition of 2 mM external Ca 2+ initiated SOCE within 3 h in LPS-treated cultures.
To determine whether LPS-associated SOCE increase might induce Ca 2+ overload, we blocked KCa3.1 and Orai1 channels with 1 μM senicapoc or 10 μM 2-aminoethoxydiphenyl borate (APB), then measured ER Ca 2+ release and cellular Ca 2+ influx after store depletion (Fig. 4A ). Blockade of either KCa3.1 or Orai1 abolished astrocyte Ca 2+ influx T. Wei, et al. Neurobiology of Disease 132 (2019) 104588 induced by store depletion, as compared with the response in control cells. Differences in Ca 2+ transport in WT and KO astrocytes were consistent with KCa3.1 regulation of SOCE in LPS-induced astrocyte activation. [Ca 2+ ] i was assayed with or without 10 μg/ml LPS for 3 h in WT or KO astrocytes. LPS-induced Ca 2+ influx was significantly lower in KO than WT + LPS astrocytes (Fig. 4B) . The results suggested that KCa3.1 and Orai1 regulate SOCE and cytosolic Ca 2+ homeostasis in astrocytes and are responsible for Ca 2+ overload in the promotion of neuroinflammation.
Orai1 was expressed in primary cultures of cortical astrocytes and was found to be associated with LPS-induced TNF-α and IL-6 production. To investigate KCa3.1 activity and the involvement of Orail and SOCE channels in neuroinflammation, we stimulated confluent primary cultures of astrocytes with 10 μg/ml LPS for 1, 3, 5, or 7 days. As shown in Fig. 4 , LPS induced a time-dependent upregulation of both KCa3.1 and Orail proteins expression ( Fig. 4C, D) . The absence of KCa3.1 expression was tested in the brains of KCa3.1 KO mice (Supplement Fig.  S2 ). . Data represent mean ± SEM (n = 12-16). ## p < .01 versus WT mice. ⁎ p < .05, ⁎⁎ p < .01 versus WT + LPS mice. (E) Cortex and hippocampal CA1 neurons as revealed by NeuN immunohistochemistry. Quantification of neuron number/0.01mm 2 in cortex and hippocampus (n = 6-8). Data represent mean ± SEM. # p < .05 compared with WT mice. ⁎ p < .05, ⁎⁎ p < .01 versus WT + LPS group mice. One-way ANOVA followed by the Dunnett's multiple comparison test. WT, wild-type; KO, knockout. Scale bar: 50 μm. FeH, Cellular localization of KCa3.1 channels in mouse brains following LPS stimulation. Double immunofluorescence analysis of KCa3.1 (green) levels in (F) astrocytes (GFAP, red), (G) microglia (Iba-1, red), and (H) neurons (NeuN, red) of control and LPSstimulated mouse brain. DAPI (blue) was used to label nuclei. Scale bar: 50 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) T. Wei, et al. Neurobiology of Disease 132 (2019) 
KCa3.1 is required for LPS-induced reactive astrogliosis and resultant neurotoxicity
We investigated the involvement of KCa3.1 in LPS-induced reactive astrogliosis by pharmacological blockade with the KCa3.1 antagonist senicapoc and in astrocytes from KCa3.1 −/− knockout mice. Senicapoc attenuated LPS-induced decreases in astrocyte viability at concentrations of 0.1, 1, 10, and 20 μM in a dose dependent manner (Fig. 5A) . Astrocytes from WT or KO mice were generated as described in methods and treated for 3 h with 10 μg/ml LPS, labeled with Fluo-4 AM in the absence of LPS (30 min) and rested for 30 min. SOCE was induced by cells stimulation with 2 μM Tg in Ca 2+ -free culture medium (0 mM Ca 2+ ) followed by addition of 2 mM Ca 2+ . (A) Calcium influx of astrocytes after treatment with 10 μg/ml LPS for 3 h with or without 1 μM senicapoc or 10 μM 2-APB pretreatment 1 h. # p < .05 versus control cells; ⁎ p < .05 versus LPS group cells. (B) Calcium influx of WT or KO astrocytes after treatment with 10 μg/ml LPS for 3 h. ### p < .001 versus WT cells; ⁎⁎⁎ p < .001 versus WT-LPS group cells. Data represent mean ± SEM (n = 3). One-way ANOVA followed by the Dunnett's multiple comparison test. Ctrl, control; Se, senicapoc; WT, wild-type; KO, knockout. (C) Western blot analysis of KCa3.1 and Orai1 expression after 10 μg/ml LPS-treatment for 1, 3, 5, 7 days. Data represent the mean ± SEM of KCa3.1 and Orai1 density normalized to β-actin values for n = 3 cultures. ⁎ p < .05, ⁎⁎ p < .01, one-way ANOVA followed by the Dunnett's multiple comparison test compared with control. (D) Double immunofluorescence images of KCa3.1 and Orai1 in cultured astrocytes with or without 10 μg/ml LPS treatment for 3 days. DAPI (blue) was used to label nuclei. Scale bar: 50 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
T. Wei, et al. Neurobiology of Disease 132 (2019) 104588 The effect of LPS on cell viability was inhibited in astrocytes from KCa3.1 −/− KO mice, as compared with astrocytes from WT mice (Fig. 5D ). The results revealed that KCa3.1 is involved in the LPS-induced inflammatory response of primary astrocytes. Pretreatment with 0.1, 1, or 10 μM senicapoc decreased the TNF-α and IL-1β concentrations in astrocyte culture supernatants after a 48 h exposure to 10 μg/ml LPS (Fig. 5B, C) . Increases in LPS-induced TNF-α and IL-1β were attenuated in astrocytes from KO mice compared with those from WT cells (Fig. 5E, F) . The effect of senicapoc on cell viability was studied in primary astrocytes (Supplement Fig. S3 ). Damage of dendrites and synapses occurs early in AD (Szegedi et al., 2006) . We evaluated the regulation of astrogliosis-mediated neurotoxicity by KCa3.1 in mouse neurons cultured in conditioned medium from 10 μg/ml LPS, 50 ng/ml TNF-α, or 10 ng/ml IL-1β stimulated astrocytes (ACM, Fig. 5G-I) . Incubation with ACM from LPS, TNF-α, or IL-1β stimulation for 48 h decreased neurite length and branching, but not cell body area, as compared with those in control cultures (Fig. 5G-I) . Pharmacological blockade with 1 μM senicapoc (Fig. 5G, I) or gene deletion of KCa3.1 (Fig. 5H, I ) significantly reversed the effects of the ACM from LPS, TNF-α, or IL-1β, as shown by an upregulation of neurite length and branching ( Fig. 5G-I) . As shown in Supplement Fig. S3 , the levels of dendritic marker MAP2 were compared between neurons treated with 10 μg/ml LPS for 48 h with or without pretreatment of 1 μM senicapoc (Supplement Fig. S4 ).
We stimulated confluent primary cultures of astrocytes with 50 ng/ ml TNF-α or 10 ng/ml IL-1β for 1, 3, 5, or 7 days. As shown in Fig. 5J , both TNF-α and IL-1β induced a time-dependent upregulation of KCa3.1 proteins expression ( Fig. 5J) . Together, the results showed that KCa3.1 is indirectly involved in neurotoxicity associated with LPS-induced astrogliosis. astrocytes with or without stimulation with 10 μg/ml LPS for 48 h. Data represent mean ± SEM (n = 3). ## p < .01 versus WT cells, ⁎⁎ p < .01 versus WT + LPS group cells. (E, F) WT or KO astrocytes were stimulated with or without 10 μg/ml LPS for 48 h. Cytokine levels TNF-α (E) and Il-1β (F) in the medium were measured by ELISA. Data represent mean ± SEM (n = 3). ## p < .01, ### p < .001 versus WT cells, ⁎⁎ p < .01, ⁎⁎⁎ p < .001 versus WT + LPS group cells. (G-I) Levels of dendritic marker MAP2 were compared between neurons treated with ACM from WT or KO astrocytes with 10 μg/ml LPS, 50 ng/ml TNF-α, or 10 ng/ml IL-1β stimulation for 48 h with or without pretreatment of 1 μM senicapoc or 10 μM 2-APB. Cell body area, neurite length and branch point counts were analyzed by Extended Neurite Outgrowth bioapplication software. Data represent mean ± SEM (n = 3). ⁎ p < .05, ⁎⁎ p < .01, ⁎⁎⁎ p < .001 (one-way ANOVA followed by the Dunnett's multiple comparison test). (J) Western blot analysis of KCa3.1 expression after 50 ng/ml TNF-α or 10 ng/ml IL-1β stimulation for 1, 3, 5, 7 days. Data represent mean ± SEM (n = 3). ⁎ p < .05, ⁎⁎ p < .01 versus control. (K) Western blotting showed the expression of LPS-stimulated p-P65 and p-IκB with the pretreatment of senicapoc or 2-APB. Data represent mean ± SEM (n = 3). ## p < .01 versus control; ⁎⁎ p < .01 versus LPS group cells. (L) Western blotting showed that compared with the control, p38 MAPK inhibitor SB20358, JNK inhibitor SP600125, ERK inhibitor U0126 and PI3K/AKT inhibitor LY294002 attenuated LPS-induced expression of p-P65 and p-IκB. Data represent mean ± SEM (n = 3). # p < .05 versus control; ⁎ p < .05, ⁎⁎ p < .01 versus LPS group cells. (M) Western blotting showed the expression of p-P65 and p-IκB in WT and KO astrocytes with LPS stimulation. Data represent mean ± SEM (n = 3). # p < .05, ## p < .01 versus WT; ⁎⁎ p < .01 versus WT + LPS group cells. (N) Western blotting showed the expression of p-IR, p-Tau, p-AKT and p-GSK3β in LPS-stimulated astrocytes with or without the pretreatment of senicapoc or 2-APB. Data represent mean ± SEM (n = 3). ## p < .01, ### p < .001 versus WT; ⁎ p < .05, ⁎⁎ p < .01, ⁎⁎⁎ p < .001 versus WT + LPS group cells. One-way ANOVA followed by the Dunnett's multiple comparison test.
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3.6. KCa3.1 and Orai1 are involved in LPS-induced NF-κB activation in astrocytes
As shown in Fig. 5B -F, increased expression of the cytokines IL-1β and TNF-α in response to LPS required activation of the transcription factor NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells). The results suggested that KCa3.1 and Orai1 mediated the NF-κB activation associated with neuroinflammation. Western blotting analysis confirmed that LPS increased the nuclear translocation of the p65 NF-κB subunit and phosphorylated (p)-IκB and that these effects were attenuated by the KCa3.1 antagonist senicapoc and the Orai1 antagonist 2-APB ( Fig. 5K) , or deletion of the KCa3.1 gene (Fig. 5M) .
The events linking LPS-induced, KCa3.1-and Orai1-mediated Ca 2+ influx to activation of the NF-κB signaling pathway were investigated with a series of antagonists and pharmacological inhibition experiments. The findings suggested that after LPS exposure, the MAPK and AKT signaling pathways are involved in KCa3.1-mediated NF-κB activation. Western blotting showed that a 30 min exposure of astrocytes to LPS, an ERK inhibitor (10 μM U0126), a JNK inhibitor (10 μM SP600125), a p38 MAPK inhibitor (20 μM SB20358), and a PI3K inhibitor (20 μM LY294002), attenuated LPS-induced upregulation of p65 nuclear translocation and IκB phosphorylation (Fig. 5L ).
Insulin resistance leads to Tau hyperphosphorylation by inhibiting AMPK-induced Tau dephosphorylation and promoting aberrant activation of GSK3β through the PI3K/AKT pathway (Kim et al., 2015; Schubert et al., 2004) . The results suggest that KCa3.1 promotes accumulation of Tau and insulin signaling deficits during astrogliosis. Western blotting analysis revealed significantly lower expression of insulin receptor and higher expression of p-Tau in LPS-stimulated astrocytes than in controls (Fig. 5N ). KCa3.1 blockade with senicapoc or 2-APB attenuated the LPS-induced changes in insulin receptor and p-Tau expression and was accompanied by a significant decrease in Akt phosphorylation and GSK3β activation (Fig. 5N) .
Reactive astrocyte transcriptome expression requires KCa3.1 deficiency
Hierarchical clustering of the LPS-stimulated WT and KO reactive astrocyte populations (Fig. 6A) revealed differences in astrogliosis transcriptomes that corresponded to KCa3.1 status. The transcriptomes included 835 differentially upregulated and 766 differentially downregulated genes with four-fold or greater differences in expression in KO-LPS compared with WT-LPS astrocytes (Fig. 6B) ; 15,978 genes were common to both types of astrocytes. The 50 upregulated genes with the greatest differences in expression are listed in Table 1 . The 50 genes with the greatest degree of downregulation are listed in Table 2 . The 20 most enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in the WT-LPS versus KO-LPS reactive astrocytes are shown in Fig. 6C . The Gene Ontology Consortium classification (http://www. godatabase.org/cgi-bin/amigo/go.cgi) biological process-and class-associated genes with more than four-fold enrichment in WT-LPS and KO-LPS reactive gene sets are shown in Fig. 6D . The most prominent were proteins that function in cell adhesion, phagosomes, neuroactive ligand-receptor interactions, and signaling pathways. The 38 pathways with the most significant enrichment are shown in Table 3 . The genes in each of the categories with more than four-fold enrichment in KO-LPS versus WT-LPS reactive astrocytes are listed in Table 4 . According to the RNA-seq data (Supplement Fig. S5 ), LPS can induce A1 phenotype switch in vitro, which was consistent with the previous report in vivo (Liddelow et al., 2017, Nature) .
Hierarchical clustering generated a heat map of genes that regulate major histocompatibility complex, cellular adhesion and natural killer cell-mediated cytotoxicity and were found to have significantly increased expression after LPS stimulation for 24 h (Fig. 6E ). The bar graph in Fig. 6E shows the average fold change of those genes in WT-LPS and KO-LPS reactive astrocytes. The H2-D1, H2-Q1, H2-BI, H2-T10 , H2-M2, and H2-T3 genes were more strongly induced in WT-LPS reactive astrocytes than KO-LPS cells. Hierarchical clustering showed that the differences in gene expression were partially attributable to variations in WT and KO astrocyte response during LPS-induced cytokine signaling and neuroinflammation (Fig. 6F) , but even within that gene classes, differences in induction were clear (Fig. 6F ). For example, Il20rb and Ccr1 were increased four-fold; Ccl12 and Ccl19 were increased two-fold; and Cxcr5 and Il13 were increased five-fold.
Discussion
Deletion of the gene encoding KCa3.1 decreased the inflammatory response and contributed to attenuation of memory deficits, neuron loss, gliosis, Tau accumulation, and insulin signaling deficits in neuroinflammatory disease. The KCa3.1-induced Tau accumulation and insulin signaling deficits in astrogliosis were both mediated by the PI3K/AKT/GSK3β or NF-κB signaling pathways. KCa3.1 and Orai1 transport contributed to LPS-mediated Ca 2+ overload and the increased inflammatory response of reactive astrogliosis.
Microglia and astrocytes regulate the severe inflammation that occurs in neurodegenerative diseases (Meraz-Rios et al., 2013; Schilling et al., 2004) . Sustained microglial activation and reactive astrogliosis promote chronic dysregulation of glial cells, and subsequent deterioration of brain structure and function (Leszek et al., 2016; Steardo Jr. et al., 2015) . Liddelow et al. have reported that A1 reactive astrocytes induced by activated microglia kill neurons and oligodendrocytes. A1 reactive astrocytes are present in human neurodegenerative diseases, including AD and Parkinson's disease. The decreased inflammatory response to LPS demonstrated by astrocytes from KO mice suggested that KCa3.1 is involved in regulating the phenotype switch to astrogliosis in WT astrocytes. KCa3.1 activity was reported to be required for microglial-induced neurotoxicity (Maezawa et al., 2011) . We tested the role of KCa3.1 during microglial activation in LPS-induced mice by Iba1 immunostaining in vivo. The Iba1 staining in the cortex and hippocampus of KO + LPS group mice was significantly decreased compared to the WT + LPS group ( Fig. 2A) . So the genetic deficiency of KCa3.1 reduced LPS-induced memory deficits and neuronal loss, which could also be partly mediated via inhibiting microglia activation. NF-κB activation is known to influence proinflammatory gene expression, and LPS-induced NF-κB activation was lower in KCa3.1-deficient than in WT astrocytes. According to our RNA-seq data (Supplement Fig. S5 ), LPS can induce A1 phenotype switch in vitro, which was consistent with the previous report in vivo (Liddelow et al., 2017, Nature) . As shown in Fig. 5 , gene deletion or pharmacological blockade of KCa3.1 attenuated the TNF-α and IL-1β concentrations in astrocyte culture supernatants, thus resulting in attenuating the synapses injury during neuroinflammation.
Transient increases in [Ca 2+ ] i result in prolonged approximately 60% site-selective increases in tau phosphorylation at the Tau-1 epitope via a glycogen synthase kinase 3 beta (GSK-3β)-dependent pathway (Hartigan and Johnson, 1999) . Calcineurin, Ca 2+ /calmodulin dependent protein phosphatase, is reported to have a link between dysregulation of Ca 2+ and the astrocyte phenotype switch. Calcineurin-dependent transcription factor nuclear factor of activated T cells (NFAT) is also upregulated in reactive astrogliosis in neurodegeneration disease mice models. Calcineurin/NFAT signal pathway hyperactivation of reactive astrogliosis is involved in the process of neuroinflammation and synapse dysfunction (Sompol and Norris, 2018) .
Ca 2+ mobilization from astrocyte ER stores is key in brain functioning. For example, regenerative opening of ER Ca 2+ channels increases astrocyte [Ca 2+ ] i , which in turn regulates neuronal plasticity (Khakh and McCarthy, 2015; Newman, 2015) . The channels that regulate SOCE and thus maintain Ca 2+ homeostasis in astrocytes are unclear. The SOCE channels that regulate Ca 2+ influx in nonexcitatory cells such as astrocytes and microglia include an ER calcium sensor (STIM) and a pore protein (Orai1). The STIM1 and Orai1 proteins have been identified in primary cultured cortical astrocytes, and SOCE is T. Wei, et al. Neurobiology of Disease 132 (2019) 104588 (caption on next page) T. Wei, et al. Neurobiology of Disease 132 (2019) 104588 Fig. 6 . LPS-induced phenotype switch of reactive astrocytes with KCa3.1 deficiency has overlapping but distinct sets of induced genes. A, A heat map was generated by hierarchical clustering using the relative expression of each probe set is indicated by colour intensity, where green indicates lower expression and red indicates higher expression in 24 h LPS-treated WT and KO astrogliosis. B, Volcano map shows the 17579 genes expressed in WT-LPS and KO-LPS, the abscissa is log2 Fold Change and the ordinate is -log10 (p-value). The two vertical dotted lines in the figure are the two-fold difference threshold; the horizontal dotted line is the threshold, p-value = .05. (red, increase; blue, decrease; gray, no change). Differential expression analysis comparing WT-LPS and KO-LPS reactive astrocytes identified the 835 genes significantly upregulated and 766 genes significantly downregulated compared with the WT-LPS reactive astrocytes. 15978 genes are common to both types of reactive astrocytes. C, The KEGG Pathway Enrichment shows the top 20 pathways that enriched in WT-LPS vs KO-LPS reactive astrocytes. D, Pie charts show the Gene Ontology categorization of WT-LPS and KO-LPS reactive gene sets. Cell adhesion, phagosome, neuroactive ligand-receptor interaction and signaling pathway are prominent classes. E, A heat map was generated by hierarchical clustering using major histocompatibility complex/cellular adhesion/natural killer cell-mediated cytotoxicity genes whose expression was significantly induced after 24 h LPS stimulation. (red, increase; blue, decrease; gray, no change). The bar graph shows the fold induction of genes within the class in WT-LPS reactive astrocytes (red) and KO-LPS reactive astrocytes (blue). All replicates within a class were averaged to obtain the fold induction. Major histocompatibility complex/cellular adhesion/natural killer cell-mediated cytotoxicity genes H2-D1,  H2-Q1, H2-BI, H2-T10, H2-M2 , and H2-T3 are more strongly induced in WT-LPS reactive astrocytes than KO-LPS cells. F, A heat map was generated by hierarchical clustering of resting and reactive astrogliosis populations using cytokine signaling genes whose expression is significantly induced after 24 h LPS stimulation in both WT and KO cells. (red, increase; blue, decrease; gray, no change). The bar graph shows fold induction of cytokine signaling genes in WT-LPS reactive astrocytes (red) and KO-LPS reactive astrocytes (blue). All replicates within a class were averaged to obtain the fold induction. The cytokines Csf2rb2, Cx3cr1, Dock2, Ncf1, and Vav1 are similarly induced in both WT-LPS and KO-LPS reactive astrocytes. The cytokines Ccl12, Ccl19, Cxcr5, Ccr1, Il20rb, and Il13 are more strongly induced in KO-LPS reactive astrocytes. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) T. Wei, et al. Neurobiology of Disease 132 (2019) 104588 involved in LPS-induced production of the cytokines TNF-α and IL-6 in astrocytes. The KCa3.1 channel and Orai1 protein in the human lung mast cell plasma membrane have been reported to mediate SOCE. Ca 2+ -bound calmodulin was also reported to bind to the core region of activated STIM1, which involved in slowing Ca 2+ -dependent inactivation after STIM1-induced the activation of Orai1 channel. The calmodulin binding site on STIM1 is close to the STIM1/Orai1 coupling region. The binding of calmodulin to activated STIM1 disrupts both the STIM1/Orai1 complex and the STIM1 oligomer, thereby inducing deactivation of the SOCE (Li et al., 2017) . Senicapoc (ICA-17043) is a selective KCa3.1 inhibitor with an IC 50 of 11 nM in the sickle cell anemia model in which it was first described (Ataga et al., 2006; Stocker et al., 2003) . More recently, (Staal et al., 2017) reported that senicapoc attenuates peripheral nerve injury in a rat model and inhibits the KCa3.1 channel in rat microglia. Another KCa3.1 inhibitor, TRAM-34, has been found to block the release of reactive oxygen species and IL-1β in microglia (Kaushal et al., 2007; Khanna et al., 2001) . Senicapoc may be more useful than TRAM-34 as a KCa3.1 blocker in studies of neurodegenerative disease models because it has several fold higher brain concentrations in the brain.
Neuronal circuits involved in glucose sensing in the CNS have been described, but the involvement of glial cells is unclear and central insulin signaling may be involved in regulating systemic glucose metabolism. Ablation of astrocyte insulin receptors has been shown to affect cellular morphology, circuit connectivity, and mitochondrial function (Zakaria et al., 2016) . The molecular mechanisms of the insulin signaling deficit that occurs in AD pathogenesis are unclear, but Tau hyperphosphorylation has been found to induce oligomeric insulin accumulation and insulin resistance in neurons (Rodriguez-Rodriguez et al., 2017).
Insulin retention causes insulin resistance in Table 3 Enrichment analysis of pathways induced in KO-LPS vs WT-LPS reactive astrocytes.
Pathways p Value Genes
Cell adhesion molecules (CAMs) 1.20E-10 Itgb2 Itgb7 Madcam1 H2-M10.2 Itga4 Siglec1 Itgam Itgal Cdh5 H2-Aa F11r H2-T24 H2-T22 H2-Q7 H2-K1 H2-T23 H2-Q10 H2-Ab1 H2-DMb1 Nrxn3 Nrcam Spn H2-Q1 Ocln Ncam2 H2-T10 H2-Bl Cldn23 L1cam Sele Cldn1 Cldn2 Cntn1 Cdh1 Cldn10 Gm11127 H2-T3 Vtcn1 Cytokine-cytokine receptor interaction 4.63E-10 Tnfsf10 Osm Ccl12 Cxcl3 Ccl19 Cxcl9 Il15 Il10 Cxcl14 Il23r Csf1r Ccl4 Cxcr5 Cd70 Ccr1 Tnfrsf1b Tnfrsf11a Cxcl10 Il21r Tnfrsf8 l20rb Tnfsf13b Il3 Ccl5 Csf2rb2 Ccl27a Ccl3 Csf3 Csf2ra lIl10ra Tnfsf9 Tnf Cx3cr1 Csf2rb Cxcl11 Bmp7 Tnfsf18 Il6ra Tslp Lta Pdgfra Ccl20 Edar Kitl Tgfb2 Gm20878 Cxcl1 Ccr5 Tnfsf8 Gm13305 Natural killer cell mediated cytotoxicity 1.98E-08 H2-M10.2 Tnfsf10 Rac3 Lcp2 Fcer1g Sh2d1b1 H2-Q10 Tyrobp H2-T22 H2-K1 Ptpn6 H2-Q7 Cd48 Cd244 Itgb2 Rac2 Ptk2b Raet1d Vav1 Tnf Itgal Fcgr4 H2-T23 H2-T24 H2-Q1 Shc4 H2-T10 H2-Bl Raet1e H2-T3 Gm11127 ECM-receptor interaction 2.36E-06 Itga2 Itgb7 Col6a4 Col1a2 Col2a1 Gp6 Spp1 Itga4 Reln Tnr Hmmr Col6a2 Lama3 Itga11 Lama1 Col4a3 Sv2c Sv2b Itga7 Col6a5 Phagosome 3.75E-06 Itga2 H2-M10.2 Msr1 Ctss Tubb3 H2-Q10 H2-T22 Coro1a Clec7a H2-K1 H2-Aa Fcgr1 H2-Q7 Fcgr2b Itgb2 H2-Ab1 Ncf2 Itgam Ncf1 Fcgr4 H2-DMb1 H2-T23 H2-T24 C1rb H2-Q1 H2-Bl H2-T10 Pla2r1 Sftpa1 Gm11127 H2-T3 Antigen processing and presentation 6.39E-06 H2-M10.2 Hspa1l Ctss H2-Ab1 Tnf Hspa1b H2-Q10 H2-T22 H2-K1 H2-Aa H2-DMb1 H2-Q7 H2-T24 H2-T23 H2-Q1 H2-T10 H2-Bl H2-T3 Gm11127 NOD-like receptor signaling pathway Shown are the top 38 pathways identified using enrichment analysis of pathways of genes enriched in LPS reactive astrocytes.
T. Wei, et al. Neurobiology of Disease 132 (2019) 104588 hyperphosphorylated Tau-bearing neurons, a neuropathological concept that may have potential therapeutic value. In this study, both insulin and hyperphosphorylated Tau increased in LPS-induced neuroinflammation in vitro and in vivo. Tau hyperphosphorylation and accumulation can be induced by altered insulin signaling (Avila, 2008; Liu et al., 2009) , and brain neuroinflammation has been reported to underlie insulin signaling deficits in AD (Bomfim et al., 2012) .
In peripheral immune cell, KCa3.1 channels involve in human T cell cytokine release and motility (Chimote et al., 2013) . KCa3.1 channels are a part of the immunological synapse signaling complex upon T cellantigen presentation (Nicolaou et al., 2007) . Immunosuppression by Nmethyl-D-aspartate receptor antagonists is mediated via KCa3.1 channels inhibition in B cells (Simma et al., 2014) . KCa3.1 was reported to be involved in the process of reactive astrocytes in CNS (Yu et al., 2014) . Expression profiling provides an approach to learning the molecular mechanism of KCa3.1 regulates the phenotype switch of astrogliosis. Our LPS-induced WT and KO reactive astrocyte transcriptomes show that reactive astrocytes undergo extensive gene expression changes between WT-LPS and KO-LPS groups. The transcriptomes included 835 differentially upregulated and 766 differentially downregulated genes with four-fold or greater differences in expression in KO-LPS compared with WT-LPS astrocytes (Fig. 6B) . The most prominent were proteins that function in phagosomes (12%), signaling pathways (12%), cell adhesion (11%), neuroactive ligand-receptor interactions (11%), natural killer cell mediated cytotoxicity (8%), and antigen processing and presentation (8%). Our gene profiles strongly suggest that LPS-induced reactive astrocytes are neuroinflammation. They more strongly express high levels of natural killer cell mediated cytotoxicity, antigen processing and presentation, and phagosome, including H2-Q1, H2-T3 and H2-BI. With the gene deletion of KCa3.1, the express levels of H2-Q1, H2-T3 and H2-BI were attenuated in the KO-LPS group. The transcriptomes are consistent with the result that KCa3.1 is indirectly involved in neurotoxicity associated with LPS-induced astrogliosis (Fig. 5) .
In this study, both gene deletion and pharmacological blockade of KCa3.1 decreased LPS-induced Tau accumulation and increased insulin receptor expression via the AKT/GSK3β signaling pathway. Pharmacological blockade of KCa3.1 decreased CNS glia inflammation, including reactive astrogliosis and microglial activation. We conclude that KCa3.1 deficiency inhibits LPS-induced proinflammatory responses in primary astrocyte cultures. In vivo KCa3.1 deficiency decreases LPSinduced memory deficits, neuronal loss, glial activation, Tau phosphorylation, and insulin signaling deficits. The data suggest that KCa3.1 has potential as a therapeutic target in neuroinflammation.
Table 4
Groupings of induced genes based on GO enrichment and KEGG enrichment.
GO enrichment grouping Genes
Cell adhesion Itgb7 Itgam H2-Aa H2-T24 H2-T22 H2-K1 H2-T23 H2-Ab1 H2-DMb1 H2-Q1 H2-T10 H2-Bl Cntn1 Cdh1 Cldn10 Gm11127 H2-T3v Vtcn1 Cytokine activity Ccl19 Cxcr5 Il20rb Il3 Csf2rb2 Cx3cr1 Tslp Kitl Gm13305 Ntural killer cell mediated cytotoxicity Fcer1g Sh2d1b1 H2-T22 H2-K1 Raet1d H2-T23 H2-T24 H2-Q1 H2-T10 H2-Bl H2-T3 Gm11127 Phagosome Itga2 Tubb3 H2-T22 H2-K1 H2-Aa Fcgr1 Fcgr2b H2-Ab1 C1rb H2-Q1 H2-Bl H2-T10 Sftpa1 Gm11127 H2-T3 H2-DMb1 H2-T23 H2-T24 Antigen processing and presentation Hspa1l H2-Ab1 H2-T22 H2-K1 H2-Aa H2-DMb1 H2-T24 H2-T23 H2-Q1 H2-T10 H2-Bl H2-T3 Gm11127 Digestive system Slco1a6 Abcb4 Slco1a5 Fxyd2 Slc5a1 Sctr Kcnn4 Col6a4 Fxyd2 Slc1a1 Col6a5 Immune system Il3 Fcgr1 Cd59a Gm13305 Kitl Cnr2 Cldn10 Itgb7 H2-Ab1 H2-Aa H2-DMb1 Neuroactive ligand-receptor interaction Grm8 Ltb4r2 Hrh2 Grik3 Gipr Chrna4 Sctr Trhr Gal Gabrg1 Gabra2 Grm5 Npy6r Adra2c Ptger3 Glp1r Gabra4 Endocrine system development Irs4 Ptger3 Prkg2 Signal transduction Fxyd2 Calml4 Gli1 Gipr Ptger3 Glp1r Glutamatergic synapse Pla2g4b Grm8 Grik3 Slc1a1 Grm5 Slc17a8 Grik1 Platelet activation Pla2g4b Fcer1g Gp6 Prkg2 Gucy1b1 Signaling pathway Calml4 Pdgfra Kitl Angpt4 Pla2g4b Il3 Fcer1g Pycard Pstpip1 Itga2 Nlrp1a Pla2g4b Fcer1g Grm8 Grm5 Kitl Ccl19 Cxcl11 Cxcr5 Cardiac muscle contraction Fxyd2 Cacng4 Cacna2d3 Complement activation Procr Cfi C1rb Cd59a
Reactive astrogliosis genes more than fourfold induced by LPS and grouped by GO enrichment and KEGG enrichment.
